Previous Close | 11.94 |
Open | 11.72 |
Bid | 11.91 x 100 |
Ask | 12.11 x 100 |
Day's Range | 11.38 - 12.02 |
52 Week Range | 3.35 - 16.40 |
Volume | |
Avg. Volume | 1,319,868 |
Market Cap | 625.96M |
Beta (5Y Monthly) | 0.76 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.42 |
Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 23.50 |
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?